Squiers L, Bright MA, Finney Rutten LJ, Atienza AA, Treiman K, Moser RP, Hesse B (2006) Awareness of the National Cancer Institute’s Cancer Information Service: results from the Health Information National Trends Survey (HINTS). J Health Commun 11:117–133

Article  PubMed  Google Scholar 

Stein GS, Pardee AB (2004) Cell cycle and growth control: biomolecular regulation and cancer, John Wiley & Sons

McKinnell RG, Parchment RE, Perantoni AO, Pierce GB, Damjanov I (2006) Genetics and heredity. Cambridge University Press, The Biological Basis of Cancer, pp 126–144

Google Scholar 

Pollock PM, Meltzer PS (2002) Lucky draw in the gene raffle. Nature 417:906–907

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

Article  CAS  PubMed  Google Scholar 

Fearon E, Bommer G (2008) Progressing from gene mutations to cancer

Croce CM (2008) Oncogenes and cancer. N Engl. J. Med. 358:502–11

Article  CAS  PubMed  Google Scholar 

Krug U, Ganser A, Koeffler HP (2002) Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 21:3475–3495

Article  CAS  PubMed  Google Scholar 

Rak J (2013) Extracellular vesicles–biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 4:21

Article  PubMed  PubMed Central  Google Scholar 

Chabner BA, Roberts TG (2005) Chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72

Article  CAS  PubMed  Google Scholar 

Wu H-C, Chang D-K, Huang C-T (2006a) Targeted therapy for cancer. J Cancer Mol 2:57–66

CAS  Google Scholar 

Smith BD, DeZern AE, Bastian AW, Durie BGM (2017) Meaningful endpoints for therapies approved for hematologic malignancies. Cancer 123:1689–1694

Article  PubMed  Google Scholar 

A.S. of C. Oncology (2015) The state of cancer care in America, 2015: a report by the American Society of Clinical Oncology. J Oncol Pract 11: 79–113.

Al-Lazikani B, Banerji U, Workman P (2012) Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol 30:679–692

Article  CAS  PubMed  Google Scholar 

Aravindaram K, Yang N-S (2010) Anti-inflammatory plant natural products for cancer therapy. Planta Med 76:1103–1117

Article  CAS  PubMed  Google Scholar 

Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79

Article  PubMed  Google Scholar 

Hughes B (2010) Antibody-drug conjugates for cancer: poised to deliver? Highlighted by Genentech’s recent US regulatory submission for trastuzumab-DM1, antibody-drug conjugation technology could be heading for the mainstream in anticancer drug development. Nat Rev Drug Discov 9:665–668

Article  CAS  PubMed  Google Scholar 

Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750–763

Article  CAS  PubMed  Google Scholar 

Farnsworth RH, Lackmann M, Achen MG, Stacker SA (2014) Vascular remodeling in cancer. Oncogene 33:3496–3505

Article  CAS  PubMed  Google Scholar 

Rangaraj S, Venkatachalam R (2018) In vitro and in vivo characteristics of biogenic high surface silica nanoparticles in A549 lung cancer cell lines and Danio rerio model systems for inorganic biomaterials development. Artif Cells, Nanomed Biotechnol 46:1415–1424

Article  CAS  PubMed  Google Scholar 

Rychahou P, Bae Y, Reichel D, Zaytseva YY, Lee EY, Napier D, Weiss HL, Roller N, Frohman H, Le A-T (2018) Colorectal cancer lung metastasis treatment with polymer–drug nanoparticles. J Control Release 275:85–91

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shali H, Shabani M, Pourgholi F, Hajivalili M, Aghebati-Maleki L, Jadidi-Niaragh F, Baradaran B, Movassaghpour Akbari AA, Younesi V, Yousefi M (2018) Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line. Artif. Cells, Nanomed, Biotechnol 46:293–302

Article  CAS  PubMed  Google Scholar 

Sharma A, Gorey B, Casey A (2019) In vitro comparative cytotoxicity study of aminated polystyrene, zinc oxide and silver nanoparticles on a cervical cancer cell line. Drug Chem Toxicol 42:9–23

Article  CAS  PubMed  Google Scholar 

Shoja Y, Kermanpur A, Karimzadeh F (2018) Diagnosis of EGFR exon21 L858R point mutation as lung cancer biomarker by electrochemical DNA biosensor based on reduced graphene oxide/functionalized ordered mesoporous carbon/Ni-oxytetracycline metallopolymer nanoparticles modified pencil graphite electrode. Biosens Bioelectron 113:108–115

Article  CAS  PubMed  Google Scholar 

Song Y, Cai H, Yin T, Huo M, Ma P, Zhou J, Lai W (2018) Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Int J Nanomed 13:1585

Article  CAS  Google Scholar 

Xiao B, Viennois E, Chen Q, Wang L, Han MK, Zhang Y, Zhang Z, Kang Y, Wan Y, Merlin D (2018) Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances chemosensitization of colon cancer. ACS Nano 12:5253–5265

Article  CAS  PubMed  Google Scholar 

Yokchom R, Laiwejpithaya S, Maneeprakorn W, Tapaneeyakorn S, Rabablert J, Dharakul T (2018) Based immunosensor with signal amplification by enzyme-labeled anti-p16INK4a multifunctionalized gold nanoparticles for cervical cancer screening, Nanomedicine Nanotechnology. Biol Med 14:1051–1058

CAS  Google Scholar 

Yuan Y-G, Zhang S, Hwang J-Y, Kong I-K (2018) Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells, Oxid Med Cell Longev 2018

Zhang X, Xiao C (2018) Biofabrication of silver nanoparticles and their combined effect with low intensity ultrasound for treatment of lung cancer. J Photochem Photobiol B Biol 181:122–126

Article  CAS  Google Scholar 

Zhao H, Li L, Zhang J, Zheng C, Ding K, Xiao H, Wang L, Zhang Z (2018) C-C chemokine ligand 2 (CCl2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer. ACS Appl Mater Interfaces 10:31124–31135

Article  CAS  PubMed  Google Scholar 

Zhao Y, Sun Q, Zhang X, Baeyens J, Su H (2018) Self-assembled selenium nanoparticles and their application in the rapid diagnostic detection of small cell lung cancer biomarkers. Soft Matter 14:481–489

Article  CAS  PubMed  Google Scholar 

Zheng B, Chen L, Pan C-C, Wang J-Z, Lu G-R, Yang S-X, Xue Z-X, Wang F-Y, Xu C-L (2018) Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy. Nanomedicine 13:769–785

Article  CAS  PubMed  Google Scholar 

Zhang J, Wang L, Zhang B, Zhao H, Kolb U, Zhu Y, Liu L, Han Y, Wang G, Wang C (2018) Sinter-resistant metal nanoparticle catalysts achieved by immobilization within zeolite crystals via seed-directed growth. Nat Catal 1:540–546

Article  CAS  Google Scholar 

Conte C, Mastrotto F, Taresco V, Tchoryk A, Quaglia F, Stolnik S, Alexander C (2018) Enhanced uptake in 2D-and 3D-lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra-and intracellular environments. J Control Release 277:126–141

Article  CAS  PubMed  Google Scholar 

Chengzheng W, Jiazhi W, Shuangjiang C, Swamy MK, Sinniah UR, Akhtar M, Umar A (2018) Biogenic synthesis, characterization and evaluation of silver nanoparticles from Aspergillus niger JX556221 against human colon cancer cell line HT-29. J Nanosci Nanotechnol 18:3673–3681

Article  PubMed  Google Scholar 

Dasgupta N, Ranjan S, Mishra D, Ramalingam C (2018) Thermal Co-reduction engineered silver nanoparticles induce oxidative cell damage in human colon cancer cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Chem Biol Interact 295:109–118

Article  CAS  PubMed  Google Scholar 

Dhanapal J, Balaraman Ravindrran M (2018) Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines. Artif Cells, Nanomed Biotechnol 46:274–282

Article  CAS  PubMed  Google Scholar 

Dudhipala N, Puchchakayala G (2018) Capecitabine lipid nanoparticles for anti-colon cancer activity in 1, 2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation, Drug Dev. Ind Pharm 44:1572–1582

Article  CAS  Google Scholar 

González-Ballesteros N, Rodríguez-Argüelles MC, Prado-López S, Lastra M, Grimaldi M, Cavazza A, Nasi L, Salviati G, Bigi F (2019) Macroalgae to nanoparticles: Study of Ulva lactuca L. role in biosynthesis of gold and silver nanoparticles and of their cytotoxicity on colon cancer cell lines. Mater Sci Eng C 97:498–509

Article  Google Scholar 

Gurunathan S, Qasim M, Park C, Yoo H, Kim J-H, Hong K (2018) Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int J Mol Sci 19:2269

Article  PubMed  PubMed Central  Google Scholar 

Handali S, Moghimipour E, Rezaei M, Saremy S, Dorkoosh FA (2019) Co-delivery of 5-fluorouracil and oxaliplatin in novel poly (3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly (lactic-co-glycolic acid) nanoparticles for colon cancer therapy. Int J Biol Macromol 124:1299–1311

Article  CAS  PubMed